Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-23T16:37:42.827Z Has data issue: false hasContentIssue false
  • English
  • Français

Phantom Prescribing: Examining the Frequency of Antimicrobial Prescriptions Without a Patient Visit

Published online by Cambridge University Press:  13 December 2016

Benjamin N. Riedle ,
Linnea A. Polgreen ,
Joseph E. Cavanaugh ,
Mary C. Schroeder  and
Philip M. Polgreen
Benjamin N. Riedle
Affiliation:
Department of Biostatistics, University of Iowa, Iowa City, Iowa
Linnea A. Polgreen
Affiliation:
Department of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa
Joseph E. Cavanaugh
Affiliation:
Department of Biostatistics, University of Iowa, Iowa City, Iowa
Mary C. Schroeder
Affiliation:
Department of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa
Philip M. Polgreen*
Affiliation:
Department of Internal Medicine, University of Iowa, Iowa City, Iowa Department of Epidemiology, University of Iowa, Iowa City, Iowa
*
Address correspondence to Philip M. Polgreen, MD, MPH, University of Iowa, Departments of Internal Medicine and Epidemiology, UIHC SW34-Q GH, Iowa City, IA 52242 (philip-polgreen@uiowa.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

To investigate the scale of antimicrobial prescribing without a corresponding visit, and to compare the attributes of patients who received antimicrobials with a corresponding visit with those who did not have a visit.

DESIGN

Retrospective cohort.

METHODS

We followed up 185,010 Medicare patients for 1 year after an acute myocardial infarction. For each antimicrobial prescribed, we determined whether the patient had an inpatient, outpatient, or provider claim in the 7 days prior to the antimicrobial prescription being filled. We compared the proportions of patient characteristics for those prescriptions associated with a visit and without a visit (ie, phantom prescriptions). We also compared the rates at which different antimicrobials were prescribed without a visit.

RESULTS

We found that of 356,545 antimicrobial prescriptions, 14.75% had no evidence of a visit in the week prior to the prescription being filled. A higher percentage of patients without a visit were identified as white (P<.001) and female (P<.001). Patients without a visit had a higher likelihood of survival and fewer additional cardiac events (acute myocardial infarction, cardiac arrest, stroke, all P<.001). Among the antimicrobials considered, amoxicillin, penicillin, and agents containing trimethoprim and methenamine were much more likely to be prescribed without a visit. In contrast, levofloxacin, metronidazole, moxifloxacin, vancomycin, and cefdinir were much less likely to be prescribed without a visit.

CONCLUSIONS

Among this cohort of patients with chronic conditions, phantom prescriptions of antimicrobials are relatively common and occurred more frequently among those patients who were relatively healthy.

Infect Control Hosp Epidemiol 2017;38:273–280

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 3 , March 2017 , pp. 273 - 280
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Previous presentation: American Pharmacists’ Association Meeting; Baltimore, Maryland; March 5, 2016.

References

REFERENCES

1. Schwartz, B, Bell, DM, Hughes, JM. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials, and patients. JAMA 1997;278:944–945.CrossRefGoogle Scholar
2. Spellberg, B, Guidos, R, Gilbert, D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155–164.CrossRefGoogle Scholar
3. French, GL. The continuing crisis in antibiotic resistance. Intl J Antimicrob Agents 2010;36:S3–S7.Google Scholar
4. World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva, Switzerland: WHO, 2014.Google Scholar
5. File, TM Jr, Srinivasan, A, Bartlett, JG. Antimicrobial stewardship: importance for patient and public health. Clin Infect Dis 2014;59:S93–S96.Google Scholar
6. Huttner, B, Harbarth, S, Nathwani, D. Success stories of implementation of antimicrobial stewardship: a narrative review. Clin Microbiol Infect 2014;20:954–962.CrossRefGoogle ScholarPubMed
7. Fleming-Dutra, KE, Hersh, AL, Shapiro, DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA 2016;315:1864–1873.CrossRefGoogle ScholarPubMed
8. Costelloe, C, Metcalfe, C, Lovering, A, Mant, D, Hay, AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096.Google Scholar
9. Wagner, B, Filice, GA, Drekonja, D, et al. Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol 2014;35:1209–1228.Google Scholar
10. Drekonja, DM, Filice, GA, Greer, N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol 2015;36:142–152.Google Scholar
11. Rohde, JM, Jacobsen, D, Rosenberg, DJ. Role of the hospitalist in antimicrobial stewardship: a review of work completed and description of a multisite collaborative. Clin Ther 2013;35:751–757.Google Scholar
12. Johannsson, B, Beekmann, SE, Srinivasan, A, Hersh, AL, Laxminarayan, R, Polgreen, PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 2011;32:367–374.CrossRefGoogle ScholarPubMed
13. Hersh, AL, Beekmann, SE, Polgreen, PM, Zaoutis, TE, Newland, JG. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol 2009;30:1211–1217.Google Scholar
14. Tabah, A, Cotta, MO, Garnacho-Montero, J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 2016;62:1009–1017.Google Scholar
15. Luyt, CE, Brechot, N, Trouillet, JL, Chastre, J. Antibiotic stewardship in the intensive care unit. Crit Care 2014;18:480.CrossRefGoogle ScholarPubMed
16. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012;33:322–327.Google Scholar
17. Elligsen, M, Walker, SA, Pinto, R, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2012;33:354–361.Google Scholar
18. Kaki, R, Elligsen, M, Walker, S, Simor, A, Palmay, L, Daneman, N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011;66:1223–1230.Google Scholar
19. Finkelstein, JA, Davis, RL, Dowell, SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001;108:1–7.Google Scholar
20. Andrews, T, Thompson, M, Buckley, DI, et al. Interventions to influence consulting and antibiotic use for acute respiratory tract infections in children: a systematic review and meta-analysis. PLOS ONE 2012;7:e30334.Google Scholar
21. Gerber, JS, Prasad, PA, Fiks, AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013;309:2345–2352.Google Scholar
22. Hallsworth, M, Chadborn, T, Sallis, A, et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016;387:1743–1752.Google Scholar
23. Nyquist, AC, Gonzales, R, Steiner, JF, Sande, MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998;279:875–877.Google Scholar
24. Mangione-Smith, R, McGlynn, EA, Elliott, MN, Krogstad, P, Brook, RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 1999;103:711–718.Google Scholar
25. Bauchner, H, Pelton, SI, Klein, JO. Parents, physicians, and antibiotic use. Pediatrics 1999;103:395–401.Google Scholar
26. Research Data Assistance Center (ResDAC). Carrier RIF, overview. ResDAC website. http://www.resdac.org/cms-data/files/carrier-rif. Published 2016. Accessed May 8, 2016.Google Scholar
27. Polgreen, PM, Yang, M, Laxminarayan, R, Cavanaugh, JE. Respiratory fluoroquinolone use and influenza. Infect Control Hosp Epidemiol 2011;32:706–709.Google Scholar
28. Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis 2015;60:1308–1316.Google Scholar
29. Mehrotra A, Paone S, Martich GD, Albert SM, Shevchik GJ. A comparison of care at e-visits and physician office visits for sinusitis and urinary tract infection. JAMA Intern Med 2013;173:72–74.CrossRefGoogle Scholar
30. Uscher-Pines L, Mulcahy A, Cowling D, Hunter G, Burns R, Mehrotra A. Antibiotic prescribing for acute respiratory infections in direct-to-consumer telemedicine visits. JAMA Intern Med 2015;175:1234–1235.CrossRefGoogle Scholar
31. Uscher-Pines L, Mulcahy A, Cowling D, Hunter G, Burns R, Mehrotra A. Access and quality of care in direct-to-consumer telemedicine. Telemedicine J E Health 2016;22:282–287.CrossRefGoogle Scholar
32. Klein EY, Makowsky M, Orlando M, Hatna E, Braykov NP, Laxminarayan R. Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA. J Antimicrob Chemother 2015;70:1580–1587.Google Scholar
33. Masiero G, Filippini M, Ferech M, Goossens H. Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health 2010;55:469–478.CrossRefGoogle Scholar
Supplementary material: File

Riedle supplementary material

Appendix

Download Riedle supplementary material(File)
File 11.8 KB